These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29226859)

  • 1. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.
    Kjærgaard AG; Rødgaard-Hansen S; Dige A; Krog J; Møller HJ; Tønnesen E
    PLoS One; 2014; 9(3):e92331. PubMed ID: 24637679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis.
    Marie Relster M; Gaini S; Møller HJ; Johansen IS; Pedersen C
    Scand J Clin Lab Invest; 2018 May; 78(3):180-186. PubMed ID: 29383956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
    Andersen MN; Andersen NF; Rødgaard-Hansen S; Hokland M; Abildgaard N; Møller HJ
    Leuk Res; 2015 Sep; 39(9):971-5. PubMed ID: 26169445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
    Rainer F; Horvath A; Sandahl TD; Leber B; Schmerboeck B; Blesl A; Groselj-Strele A; Stauber RE; Fickert P; Stiegler P; Møller HJ; Grønbaek H; Stadlbauer V
    Aliment Pharmacol Ther; 2018 Mar; 47(5):657-664. PubMed ID: 29266346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
    Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
    Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
    Heftdal LD; Loft AG; Hendricks O; Ashouri Christiansen A; Schiøttz-Christensen B; Arnbak B; Jurik AG; Østgård R; Winding Deleuran B; Møller HJ; Greisen SR
    Scand J Clin Lab Invest; 2018 Oct; 78(6):483-489. PubMed ID: 30176763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose.
    Siggaard CB; Kazankov K; Rødgaard-Hansen S; Møller HJ; Donnelly MC; Simpson KJ; Grønbaek H
    Scand J Gastroenterol; 2019 May; 54(5):623-632. PubMed ID: 31067143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of the soluble haemoglobin scavenger receptor CD163 in MPO-ANCA-associated renal vasculitis.
    Nagai M; Hirayama K; Ebihara I; Higuchi T; Shimohata H; Kobayashi M
    Scand J Rheumatol; 2016 Oct; 45(5):397-403. PubMed ID: 27094919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.